Case report reveals a rare microsecretory adenocarcinoma in buccal mucosa, suggesting the need for molecular testing and distinguishing features.
Microsecretory adenocarcinoma is a recently recognized low-grade salivary gland malignancy characterized by distinct histomorphological features, a specific immunophenotype, and recurrent MEF2C::SS18 gene fusion. This report describes 43-year-old woman with a two-decade history of a right buccal mucosa mass that exhibited recent enlargement, causing functional impairment. Surgical excision revealed a well-demarcated tumor with microcystic and tubular architecture, basophilic luminal secretions, and low proliferative activity (<1 mitotic figure/2mm2). Immunohistochemistry demonstrated positivity for S-100, SOX10, keratin 7, and p63, with negativity for p40, while fluorescence in situ hybridization confirmed SS18 rearrangement. No adjuvant therapy was administered, and the patient remained recurrence-free during a 3-year follow-up. This tumor confirms the slow-growing nature of microsecretory adenocarcinoma, emphasizes the importance of molecular testing for diagnosis, and clarifies the diagnostic differences between microsecretory adenocarcinoma and similar-looking salivary gland tumors.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: